These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2450240)

  • 61. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium.
    Bethke T; Meyer W; Schmitz W; Scholz H; Wenzlaff H; Armah BI; Brückner R; Raap A
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):847-55. PubMed ID: 7687707
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Direct cardiac effects of a novel vesamicol receptor ligand, m-iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations.
    Sugiyama A; Lurie KG; Efange SM; Takehana S; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):843-7. PubMed ID: 10598128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.
    Shahid M; Martorana MG; Cottney JE; Marshall RJ
    Br J Pharmacol; 1990 Aug; 100(4):735-42. PubMed ID: 2169938
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
    Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Arterial and venous vasodilator actions of RS-1893, a novel cardiotonic agent, in the hindlimb preparation of the dog.
    Miyake S; Shiga H; Koike H
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):526-33. PubMed ID: 2478765
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coronary vasodilator and cardiac effects of optical isomers of verapamil in the dog.
    Satoh K; Yanagisawa T; Taira N
    J Cardiovasc Pharmacol; 1980; 2(3):309-18. PubMed ID: 6156328
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
    Abe Y; Ishisu R; Onishi K; Sekioka K; Narimatsu A; Nakano T
    J Pharmacol Exp Ther; 1996 Feb; 276(2):433-9. PubMed ID: 8632307
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent.
    Abe Y; Kitada Y; Narimatsu A; Tobe A
    Eur J Pharmacol; 1991 Jan; 192(2):279-85. PubMed ID: 2032560
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differences in cardiovascular profile among calcium antagonists.
    Taira N
    Am J Cardiol; 1987 Jan; 59(3):24B-29B. PubMed ID: 3544789
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preferential inhibition of Ikr by MCI-154, a putative cardiotonic Ca2+ sensitizer, in guinea pig atrial cells.
    Eto K; Hashimoto K; Nakaya H
    Cardiovasc Res; 1998 Jun; 38(3):685-94. PubMed ID: 9747436
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
    Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
    J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.
    Rump AF; Acar D; Klaus W
    Br J Pharmacol; 1994 Jul; 112(3):757-62. PubMed ID: 7921599
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effect of oxyphenamone, a new inodilator, on isolated cardiac muscles and arteries].
    Fan LL; Sun LH; Lin Y
    Yao Xue Xue Bao; 1997 Nov; 32(11):808-12. PubMed ID: 11596198
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of MCI-154, a novel cardiotonic agent, on mean circulatory filling pressure in anesthetized dogs.
    Satoh N; Abe Y; Kitada Y; Narimatsu A; Tobe A
    Eur J Pharmacol; 1990 Jan; 175(3):317-22. PubMed ID: 2108868
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1087-95. PubMed ID: 1602375
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronotropic, inotropic, dromotropic and coronary vasodilator effects of bisaramil, a new class I antiarrhythmic drug, assessed using canine isolated, blood-perfused heart preparations.
    Haruno A; Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 1999 Jul; 80(3):267-70. PubMed ID: 10461773
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one).
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(5):721-9. PubMed ID: 6182401
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Electrophysiological comparison of the effects of MCI-154 on smooth muscles between mesenteric artery and vein of dogs.
    Hashitani H; Chen G; Ono H; Seki N; Li Y; Nagao T; Suzuki H
    Gen Pharmacol; 1993 Mar; 24(2):333-40. PubMed ID: 8482518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.